Literature DB >> 1777506

Carboxy-terminal truncations of epidermal growth factor (EGF) receptor affect diverse EGF-induced cellular responses.

W Li1, N Hack, B Margolis, A Ullrich, K Skorecki, J Schlessinger.   

Abstract

The binding of epidermal growth factor (EGF) to its receptor induces tyrosine phosphorylation of phospholipase C gamma (PLC gamma), which appears to be necessary for its activation leading to phosphatidyl inositol (PI) hydrolysis. Moreover, EGF-receptor (EGF-R) activation and autophosphorylation results in binding of PLC gamma to the tyrosine phosphorylated carboxy-terminus of the receptor. To gain further insights into the mechanisms and interactions regulating these processes, we have analyzed transfected NIH-3T3 cells expressing two EGF-R carboxy-terminal deletion mutants (CD63 and CD126) with reduced capacity to stimulate PI hydrolysis, Ca2+ rises, and DNA synthesis. In fact, the CD126 mutant lacking 126 carboxy-terminal amino acids, including four tyrosine autophosphorylation sites, was unable to stimulate PI hydrolysis or Ca2+ rise in response to EGF. Surprisingly, EGF binding to the cell lines expressing CD63 or CD126 mutants was followed by similar stimulation of tyrosine phosphorylation of PLC gamma. Our results suggest that although necessary, tyrosine phosphorylation of PLC gamma may not be sufficient for stimulation and PI hydrolysis. It is clear, however, that the carboxy-terminal region of EGF-R is involved in regulation of interactions with cellular targets and therefore plays a crucial role in postreceptor signaling pathways.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1777506      PMCID: PMC361854          DOI: 10.1091/mbc.2.8.641

Source DB:  PubMed          Journal:  Cell Regul        ISSN: 1044-2030


  27 in total

1.  Src homology region 2 domains direct protein-protein interactions in signal transduction.

Authors:  M F Moran; C A Koch; D Anderson; C Ellis; L England; G S Martin; T Pawson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Analysis of mammalian fibroblast transformation by normal and mutated human EGF receptors.

Authors:  J D Haley; J J Hsuan; M D Waterfield
Journal:  Oncogene       Date:  1989-03       Impact factor: 9.867

4.  Functional heterogeneity of proto-oncogene tyrosine kinases: the C terminus of the human epidermal growth factor receptor facilitates cell proliferation.

Authors:  T J Velu; W C Vass; D R Lowy; L Beguinot
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

5.  Phospholipase C-gamma is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro.

Authors:  J Meisenhelder; P G Suh; S G Rhee; T Hunter
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

6.  Binding of SH2 domains of phospholipase C gamma 1, GAP, and Src to activated growth factor receptors.

Authors:  D Anderson; C A Koch; L Grey; C Ellis; M F Moran; T Pawson
Journal:  Science       Date:  1990-11-16       Impact factor: 47.728

7.  Tyrosine phosphorylation of a common 57-kDa protein in growth factor-stimulated and -transformed cells.

Authors:  W Li; Y G Yeung; E R Stanley
Journal:  J Biol Chem       Date:  1991-04-15       Impact factor: 5.157

8.  PDGF stimulation of inositol phospholipid hydrolysis requires PLC-gamma 1 phosphorylation on tyrosine residues 783 and 1254.

Authors:  H K Kim; J W Kim; A Zilberstein; B Margolis; J G Kim; J Schlessinger; S G Rhee
Journal:  Cell       Date:  1991-05-03       Impact factor: 41.582

9.  Increase of the catalytic activity of phospholipase C-gamma 1 by tyrosine phosphorylation.

Authors:  S Nishibe; M I Wahl; S M Hernández-Sotomayor; N K Tonks; S G Rhee; G Carpenter
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

10.  Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases.

Authors:  E Y Skolnik; B Margolis; M Mohammadi; E Lowenstein; R Fischer; A Drepps; A Ullrich; J Schlessinger
Journal:  Cell       Date:  1991-04-05       Impact factor: 41.582

View more
  2 in total

1.  Substitution of C-terminus of VEGFR-2 with VEGFR-1 promotes VEGFR-1 activation and endothelial cell proliferation.

Authors:  Rosana D Meyer; Amrik Singh; Fredric Majnoun; Catharina Latz; Kameran Lashkari; Nader Rahimi
Journal:  Oncogene       Date:  2004-07-15       Impact factor: 9.867

2.  GSK-3 inactivation or depletion promotes β-cell replication via down regulation of the CDK inhibitor, p27 (Kip1).

Authors:  Jeffrey Stein; Wieslawa M Milewski; Manami Hara; Donald F Steiner; Arunangsu Dey
Journal:  Islets       Date:  2011-01-01       Impact factor: 2.694

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.